Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board
September 26, 2018 13:09 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board
September 21, 2018 08:23 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards
September 12, 2018 08:13 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
Cannabis Science Invited to Deliver Keynote Address at European Summit Organized by The University of Heidelberg and Harvard Medical School’s Global Health Catalyst
August 31, 2018 12:35 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
CANNABIS SCIENCE TODAY LAUNCHES ITS NEW CORPORATE WEBSITE
August 21, 2018 07:48 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the launch of the...
Cannabis Science, Inc. Announces New Company Website, New Management Team Expansions, & Pushes to Complete Updated Financial Reporting Requirements
August 13, 2018 11:53 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce it is in...
Cannabis Science Celebrates the Lives and Mourns the Loss of Dr. Allen Herman and The Honorable Ronald V. Dellums
August 08, 2018 09:10 ET
|
Cannabis Science, Inc.
IRVINE, CA, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, celebrates the lives of Dr. Allen Herman,...
Cannabis Science and FSO NAC Sign for New 100-Acre Property in Minden, Nevada as the Industrial Hemp Research Projects in Nevada Continue to Flourish for the Group
July 24, 2018 12:05 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 24, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the signing of...
Cannabis Science Research Group FSO NAC / HRM Farms Receives Approvals From the Nevada Department of Agriculture for its Newest 40-Acre Industrial Hemp Research Project in Nevada
July 10, 2018 07:35 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 10, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the immediate...
Cannabis Science, Harvard Medical School’s Global Health Catalyst, Elpasso Farms (South Africa), and American States University Partner to Strengthen Africa’s Economic and Healthcare Infrastructure
July 09, 2018 08:43 ET
|
Cannabis Science, Inc.
IRVINE, CA, July 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce Harvard...